Oric Pharmaceuticals market cap ORIC
Share price times shares outstanding: what the whole company sells for, since 2020.
- Today, Nov 2, 2026
- $940.1M
- Highest close in our data
- $1.5B
- Aug 2026
Oric Pharmaceuticals is worth $940.1M at the close on Nov 2, 2026, at $9.07 a share.
That is down 22% over the last year and up 47% over five years.
Its highest close in our data was $1.5B in Aug 2026.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $940.1M | $776.4M | $1.5B | +17% |
| 2025 | $803.5M | $336.2M | $1.3B | +38% |
| 2024 | $582.2M | $459.3M | $1B | +16% |
| 2023 | $501.9M | $168.6M | $514.4M | +115% |
| 2022 | $233.1M | $97.4M | $564.3M | −60% |
| 2021 | $578.9M | $555.7M | $1.1B | −45% |
| 2020 | $1B | $591.9M | $1.2B | n/a |
Against its peers
Companies in Drug Manufacturers - General nearest Oric Pharmaceuticals' size, closest first, today.
| Company | Market cap |
|---|---|
| ORICOric Pharmaceuticals | $940.1M |
| ABUSArbutus Biopharma | $791.4M |
| COLLCollegium Pharmaceutical | $770.9M |
| AMPHAmphastar Pharmaceuticals | $1.1B |
| OMEROmeros | $1.3B |
| ANABAnaptysbio | $1.4B |
| PCRXPacira BioSciences | $1.5B |
| ZVRAZevra Therapeutics | $599.8M |
| IRWDIronwood Pharmaceuticals | $571.7M |
| PAHCPhibro Animal Health | $1.6B |
| ANIPANI Pharmaceuticals | $1.6B |
| Peer median | $1.2B |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Oric Pharmaceuticals
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.